These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3174767)
1. Metabolism of methadone by chicken embryos prevents induction of chronic opioid-type dependence after a single injection: use of osmotic pumps for continuous infusion. Seran GF; Sparber SB Pharmacol Biochem Behav; 1988 Jun; 30(2):357-63. PubMed ID: 3174767 [TBL] [Abstract][Full Text] [Related]
2. Evidence of single dose opioid dependence in 12- to 14-day-old chicken embryos. Bronson ME; Sparber SB Pharmacol Biochem Behav; 1989 Dec; 34(4):705-9. PubMed ID: 2482981 [TBL] [Abstract][Full Text] [Related]
3. Opiate withdrawal increases ornithine decarboxylase activity which is otherwise unaltered in brains of dependent chicken fetuses. Kuwahara MD; Sparber SB Life Sci; 1983 Jan; 32(5):495-502. PubMed ID: 6681649 [TBL] [Abstract][Full Text] [Related]
4. Prenatal withdrawal from opiates interferes with hatching of otherwise viable chick fetuses. Kuwahara MD; Sparber SB Science; 1981 May; 212(4497):945-7. PubMed ID: 7195069 [TBL] [Abstract][Full Text] [Related]
5. Continuous exposure of the chick embryo to l-alpha-noracetylmethadol does not alter brain protein or nucleic acid content. Kuwahara MD; Sparber SB Dev Pharmacol Ther; 1981; 3(1):12-24. PubMed ID: 6171394 [TBL] [Abstract][Full Text] [Related]
6. Suppressed fever and hypersensitivity responses in chicks prenatally exposed to opiates. Schrott LM; Sparber SB Brain Behav Immun; 2004 Nov; 18(6):515-25. PubMed ID: 15331122 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of physical dependence following chronic continuous methadone delivery via osmotic minipumps in pregnant rats. Darmani NA; Saady JJ; Schnoll SH; Martin BR Neurotoxicol Teratol; 1991; 13(6):627-30. PubMed ID: 1779950 [TBL] [Abstract][Full Text] [Related]
8. Early impact of methadone induction for heroin dependence: differential effects of two dose sequences in a randomized controlled study. Greenwald MK Exp Clin Psychopharmacol; 2006 Feb; 14(1):52-67. PubMed ID: 16503705 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence. Holtzman SG J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679 [TBL] [Abstract][Full Text] [Related]
11. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600 [TBL] [Abstract][Full Text] [Related]
12. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog. Vaupel DB; Jasinski DR J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405 [TBL] [Abstract][Full Text] [Related]
13. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Rosado J; Walsh SL; Bigelow GE; Strain EC Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480 [TBL] [Abstract][Full Text] [Related]
14. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Eap CB; Buclin T; Baumann P Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865 [TBL] [Abstract][Full Text] [Related]
15. Intermittent naloxone attenuates the development of physical dependence on methadone in rhesus monkeys. Krystal JH; Walker MW; Heninger GR Eur J Pharmacol; 1989 Feb; 160(3):331-8. PubMed ID: 2540995 [TBL] [Abstract][Full Text] [Related]
16. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine. Levin FR; Fischman MW; Connerney I; Foltin RW Am J Addict; 1997; 6(2):105-16. PubMed ID: 9134072 [TBL] [Abstract][Full Text] [Related]
17. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268 [TBL] [Abstract][Full Text] [Related]
18. Effect of chronic methadone administration on neuroendocrine function in young adult rats. Kuhn CM; Bartolome MB J Pharmacol Exp Ther; 1985 Jul; 234(1):204-10. PubMed ID: 4040169 [TBL] [Abstract][Full Text] [Related]
19. Methadone at tapered doses for the management of opioid withdrawal. Amato L; Davoli M; Ferri M; Ali R Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464 [TBL] [Abstract][Full Text] [Related]
20. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions. Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]